/ /

  • linkedin
  • Increase Font
  • Sharebar

    What everyone was tweeting about at ASCRS 2016

    Abbott announced positive results from Tecnis Symfony IOL study

     

     

    The company reported that the trial for the new IOL met its primary endpoints for improved near and intermediate vision.

    Jolie Higazi
    Jolie is the Content Specialist for Ophthalmology Times. She can be reached at [email protected]

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results